#SARSCOV2

Emeric FINCK

Que_Lenergie

L‘après #Covid19, ce serait donc des potions médicamenteuses choisies à coup de pétitions promues par les alliés des druides qui les concotent, portées aux nues par quantité d’inconscients complotistes qui

Gummi Bear

gummibear737

Deep Dive!This is an important thread about testing for SARS-CoV-2 which will explain:-why herd immunity is possible at 10-20%-why testing has really let us down and led to bad policy

Faytuks News Δ

Faytuks

#BREAKING - The epidemic/diffusion of the novel Coronavirus in Northern Italy, Lombardy shows a death rate NOT compatible with the original #COVID19 but more comparable with SARS. This indicates that

Adam Hamdy

adamhamdy

1. So what now?Long time followers will know I've been pretty relentless banging the #COVID19 drum. Pandemics ruin lives and livelihoods. This virus should have been taken far more seriously

Erin C. Sanders, MSN, WHNP-BC (She/Her)

ErinSandersNP

1/ #Frontline clinicians across the world are observing a #hypercoagulable state in patients with #COVID19. Could the severe and varied effects of the disease on multiple organ systems possibly

Alasdair Munro

apsmunro

Lots of talk about schools and #COVID19 today, which is no surprise!Time for a bumper thread on the evidence we have so far on schools, children, teachers, and #SARSCoV2 plus

Tom Bollyky

TomBollyky

There is not a lot new in the President's latest letter on @WHO handling of the #COVID19 pandemic, sent ahead of second day of #WHA73But there are few items worth

Rich Davis, PhD, D(ABMM), MLS 🦠🔬🧫

richdavisphd

Good thread on sensitivity & specificity of first emergency use authorization (EUA) #COVID19 serology test, Cellex, means for testing a low-prevalence population: increased risk of false positivesBUT IT'S ACTUALLY WORSE

Rahul Ganatra

rbganatra

1/Should we use #Lopinavir-ritonavir (LPV/r) + #Ribavirin (RBV) +/- #Interferon beta-1b (IFN) to treat #SARSCoV2 #COVID19? Let’s take a look at the data.Here’s: #HowIReadThisPaper on @TheLancet trial of triple therapy

jenabbasi

jenabbasi

Severely immunosuppressed people can battle #SARSCoV2 for months. Some virologists are convinced the #variants emerged in this setting. My latest for @JAMA_current deals with how to care for these vulnerable

⛑LynnFynn🇺🇸 🌱👩🏽‍⚕️🧬💊🥼

LynnFynn3

Teamwork... This ought to rattle some cages...1) RaTG13 is incapable of binding to a bat or a pangolin (no binding observed), and is less than 1/1000 the affinity to humans

Gregg Gonsalves

gregggonsalves

Thank you for saying this @AndrewNoymer. The "shield sensitive groups" strategy is also know as the "age-targeted" or "herd immunity" strategy. In the US, proponents are @MartinKulldorff & @SWAtlasHoover. 1

Adam Hamdy

adamhamdy

1. I've been tweeting about airborne transmission of #COVID19 in schools, and thought it might be helpful to share how we've dealt with the issue. Every family is different, so

Steven Chen

DrStevenTChen

1/Okay #medtwitter and #dermtwitter, you knew it was only a matter of time, didn’t you?! Let’s do this #COVID19 themed #medthread:#COVID TOES, a #TWEETORIAL!#MedEd #FOAMEd #dermatology #dermatologia @AADskin @AADMember @Meddermsoc

Eric Feigl-Ding

DrEricDing

BREAKING—Oxford/Astrazeneca vaccine is 70% effective overall. But one of its dosing regimens of low-then-high yields 90% effectiveness.Oxford #COVID19 vaccine cheaper than the Pfizer & Moderna vaccines, and does *not* does

ETE Fr

ete_fr

Nous sommes interpellé⋅e⋅s à propos de la #virulence plus élevée du #variant de #SARSCoV2 B.1.1.7 (ou #voc).Certain⋅e⋅s y voient des études "contradictoires".Tour d’horizon rapide avec deux études qui nous semblent